E2F5 (NM_001951) Human Recombinant Protein
CAT#: TP324285
Recombinant protein of human E2F transcription factor 5, p130-binding (E2F5), transcript variant 1
Specifications
Product Data | |
Species | Human |
Expression Host | HEK293T |
Expression cDNA Clone or AA Sequence |
Recombinant protein was produced with TrueORF clone, RC224285. Click on the TrueORF clone link to view cDNA and protein sequences.
|
Tag | C-Myc/DDK |
Predicted MW | 37.4 kDa |
Concentration | >50 ug/mL as determined by microplate BCA method |
Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol |
Preparation | Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. |
Storage | Store at -80°C. |
Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Reference Data | |
RefSeq | NP_001942 |
Locus ID | 1875 |
UniProt ID | Q15329 |
Cytogenetics | 8q21.2 |
Refseq Size | 1752 |
Refseq ORF | 1038 |
Synonyms | E2F-5 |
Summary | The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionarily conserved domains that are present in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein is differentially phosphorylated and is expressed in a wide variety of human tissues. It has higher identity to E2F4 than to other family members. Both this protein and E2F4 interact with tumor suppressor proteins p130 and p107, but not with pRB. Alternative splicing results in multiple variants encoding different isoforms. [provided by RefSeq, Jul 2008] |
Protein Families | Druggable Genome, Transcription Factors |
Protein Pathways | Cell cycle, TGF-beta signaling pathway |
Documents
FAQs |
SDS |
Resources
Recombinant Protein Resources |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC419631 | E2F5 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LC421221 | E2F5 HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
LY419631 | Transient overexpression lysate of E2F transcription factor 5, p130-binding (E2F5), transcript variant 1 |
USD 396.00 |
|
LY421221 | Transient overexpression lysate of E2F transcription factor 5, p130-binding (E2F5), transcript variant 2 |
USD 396.00 |
|
PH324285 | E2F5 MS Standard C13 and N15-labeled recombinant protein (NP_001942) |
USD 2,055.00 |
|
TP760686 | Purified recombinant protein of Human E2F transcription factor 5, p130-binding (E2F5), transcript variant 1, with N-terminal HIS tag, expressed in E.Coli, 50ug |
USD 215.00 |
{0} Product Review(s)
Be the first one to submit a review